139. The representative of El Salvador considered that the Protocol represented a triumph in the WTO negotiations on public health, which was unprecedented and highly beneficial for developing countries and least-developed countries. The Decision adopted in December 2005 would establish additional flexibilities under the TRIPS Agreement as it related to public health. Countries with no or insufficient domestic manufacturing capacities would have the right to import patented medicines produced abroad by making use of compulsory licences under the paragraph 6 system. This already formed an integral part of her country's intellectual property legislation. The system would make it possible for a country with manufacturing and export capacities to authorize the use of a compulsory licence to permit the production of medicines for export to countries in need of such medicines which have no or insufficient supply capacity.
